Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | -2.41% | 43.41 | 0.0% | $636.11m | |
| GWPH | GW Pharmaceuticals Plc | 0.36% | 214.94 | 6.1% | $394.55m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 3.39% | 32.98 | 14.1% | $194.06m | |
| HZNP | Horizon Therapeutics Plc | 2.85% | 88.65 | 5.5% | $192.84m | |
| JAZZ | Jazz Pharmaceuticals Plc | 2.68% | 164.75 | 2.3% | $186.19m | |
| BHC | Bausch Health Cos., Inc. | 3.39% | 32.98 | 0.0% | $148.25m | |
| CTLT | Catalent, Inc. | 1.33% | 104.45 | 2.1% | $106.06m | |
| ICLR | ICON plc | 4.55% | 179.83 | 4.2% | $95.66m | |
| PRGO | Perrigo Co. Plc | 1.31% | 41.10 | 6.8% | $73.07m | |
| ARGX | argenx SE | -0.53% | 289.75 | 0.0% | $71.68m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 5.37% | 1.02 | 0.2% | $57.10m | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | 1.47% | 4.15 | 6.0% | $54.26m | |
| AMRN | Amarin Corp. Plc | 4.72% | 5.99 | 1.5% | $43.81m | |
| UTHR | United Therapeutics Corp. | 2.50% | 164.34 | 14.1% | $43.26m | |
| PBH | Prestige Consumer Healthcare, Inc. | 2.69% | 43.59 | 4.0% | $42.48m |
Company Profile
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.